Literature DB >> 23352938

Notch-driven carcinogenesis: the merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtype.

Nataliya Razumilava1, Gregory J Gores.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352938      PMCID: PMC3818720          DOI: 10.1016/j.jhep.2013.01.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

Review 2.  Notch signaling: the core pathway and its posttranslational regulation.

Authors:  Mark E Fortini
Journal:  Dev Cell       Date:  2009-05       Impact factor: 12.270

3.  Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

Authors:  M Chiara Cantarini; Suzanne M de la Monte; Maoyin Pang; Ming Tong; Antonia D'Errico; Franco Trevisani; Jack R Wands
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

4.  Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.

Authors:  Sayaka Sekiya; Atsushi Suzuki
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

5.  Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.

Authors:  Augusto Villanueva; Clara Alsinet; Kilangsungla Yanger; Yujin Hoshida; Yiwei Zong; Sara Toffanin; Leonardo Rodriguez-Carunchio; Manel Solé; Swan Thung; Ben Z Stanger; Josep M Llovet
Journal:  Gastroenterology       Date:  2012-09-11       Impact factor: 22.682

6.  Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.

Authors:  Chunmei Wang; Runzi Qi; Nan Li; Zhengxin Wang; Huazhang An; Qinghua Zhang; Yizhi Yu; Xuetao Cao
Journal:  J Biol Chem       Date:  2009-04-17       Impact factor: 5.157

7.  Cholangiocarcinomas can originate from hepatocytes in mice.

Authors:  Biao Fan; Yann Malato; Diego F Calvisi; Syed Naqvi; Nataliya Razumilava; Silvia Ribback; Gregory J Gores; Frank Dombrowski; Matthias Evert; Xin Chen; Holger Willenbring
Journal:  J Clin Invest       Date:  2012-07-17       Impact factor: 14.808

8.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.

Authors:  Luke Boulter; Olivier Govaere; Tom G Bird; Sorina Radulescu; Prakash Ramachandran; Antonella Pellicoro; Rachel A Ridgway; Sang Soo Seo; Bart Spee; Nico Van Rooijen; Owen J Sansom; John P Iredale; Sally Lowell; Tania Roskams; Stuart J Forbes
Journal:  Nat Med       Date:  2012-03-04       Impact factor: 53.440

9.  Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

Authors:  Patrick Viatour; Ursula Ehmer; Louis A Saddic; Craig Dorrell; Jesper B Andersen; Chenwei Lin; Anne-Flore Zmoos; Pawel K Mazur; Bethany E Schaffer; Austin Ostermeier; Hannes Vogel; Karl G Sylvester; Snorri S Thorgeirsson; Markus Grompe; Julien Sage
Journal:  J Exp Med       Date:  2011-08-29       Impact factor: 14.307

10.  Sox9b is a key regulator of pancreaticobiliary ductal system development.

Authors:  Marion Delous; Chunyue Yin; Donghun Shin; Nikolay Ninov; Juliana Debrito Carten; Luyuan Pan; Taylur P Ma; Steven A Farber; Cecilia B Moens; Didier Y R Stainier
Journal:  PLoS Genet       Date:  2012-06-14       Impact factor: 5.917

View more
  14 in total

1.  MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.

Authors:  Valeria Canu; Andrea Sacconi; Laura Lorenzon; Francesca Biagioni; Federica Lo Sardo; Maria Grazia Diodoro; Paola Muti; Alfredo Garofalo; Sabrina Strano; Antonietta D'Errico; Gian Luca Grazi; Mario Cioce; Giovanni Blandino
Journal:  Oncotarget       Date:  2017-05-02

2.  Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.

Authors:  Hyunjoo Kwon; Kyoungsub Song; Chang Han; Jinqiang Zhang; Lu Lu; Weina Chen; Tong Wu
Journal:  Am J Pathol       Date:  2017-10       Impact factor: 4.307

Review 3.  Role of liver stem cells in hepatocarcinogenesis.

Authors:  Lei-Bo Xu; Chao Liu
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

4.  miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.

Authors:  Jing Zhang; Jingjing Jiao; Silvia Cermelli; Kyle Muir; Kwang Hwa Jung; Ruhai Zou; Asif Rashid; Mihai Gagea; Sonya Zabludoff; Raghu Kalluri; Laura Beretta
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

Review 5.  Targeting the Notch signaling pathway in cancer therapeutics.

Authors:  Huajiao Guo; Yi Lu; Jianhua Wang; Xia Liu; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

6.  MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer.

Authors:  Yujuan Yue; Kun Zhou; Jiachu Li; Shan Jiang; Chunyan Li; Haitao Men
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

Review 7.  The role of tumour microenvironment: a new vision for cholangiocarcinoma.

Authors:  Ziyan Chen; Pengyi Guo; Xiaozai Xie; Haitao Yu; Yi Wang; Gang Chen
Journal:  J Cell Mol Med       Date:  2018-11-05       Impact factor: 5.310

8.  YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.

Authors:  Xinjun Lu; Baogang Peng; Ge Chen; Mario G Pes; Silvia Ribback; Cindy Ament; Hongwei Xu; Rajesh Pal; Pedro M Rodrigues; Jesus M Banales; Matthias Evert; Diego F Calvisi; Xin Chen; Biao Fan; Jingxiao Wang
Journal:  Am J Pathol       Date:  2021-06-12       Impact factor: 5.770

Review 9.  Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.

Authors:  Chaobo Chen; Leonard J Nelson; Matías A Ávila; Francisco Javier Cubero
Journal:  Cells       Date:  2019-09-28       Impact factor: 6.600

Review 10.  Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?

Authors:  Konstantinos Laschos; Dimitra Ioanna Lampropoulou; Gerasimos Aravantinos; Maria Piperis; Dimitrios Filippou; George Theodoropoulos; Maria Gazouli
Journal:  World J Gastrointest Surg       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.